Clinical Trial Update: Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating precision treatment guided by molecular typing for recurrent or metastatic salivary gland carcinoma is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Salivary Gland Carcinoma

Snippet

Sponsor: Peking Union Medical College | Conditions: Salivary Gland Carcinoma, Precision Therapy | Phase 2 | Status: RECRUITING